The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the global mice model market are rising investments in mouse-model based research, and increasing demand of mouse-based clinical trials (MCTs) for more productive outcomes. However, the introduction of 3D-printed mouse models are expected to restrain market growth to a certain extent.
The market for mice model is highlay consolidated, with key players strategizing to capture majority of the market. Prominent players in the market are Charles River Laboratories (US), The Jackson Laboratory (US), Inotiv (US), genOway (France), Taconic Biosciences, Inc. (US), Janvier Labs (France), Harbour BioMed (China), Trans Genic Inc. (Japan), Ingenious Targeting Laboratory (US), PolyGene AG (Switzerland), Aragen Life Sciences Ltd. (India), Cyagen Biosciences (US), Crown Biosciences (US), TransCure bioServices (France), Ozgene Pty. Ltd. (Australia), The Andersons, Inc. (US), Allentown, LLC (US), Innovive (US), Lab Products, Inc. (US), Crescendo Biologics Limited (UK), ImmunoGenes (Hungary), Lexicon Pharmaceuticals, Inc. (US), Horizon Group PLC (UK). Marshall BioResources (US), and Applied StemCell Inc. (US).
To know about the assumptions considered for the study download the pdf brochure
Charles River Laboratories International, Inc. (US)
Charles River Laboratories (US) International, Inc. is a leading player in the global mice model market owing to its extensive portfolio of mice models and services. With more than 70 years of experience, the company has built upon its core competency in the field of in vivo biology through its diverse products and services portfolio. It offers products, services, and solutions that focus specifically on early-stage drug discovery and preclinical development. Its strong portfolio enables the company to increase collaboration with clients—from early lead generation to candidate selection.
With over 150 different stocks and strains, the company is engaged in the production and sale of the most widely used rodent research model strains and purpose-bred rats and mice. Charles River also provides a variety of related services that are designed to support clients in the use of research models in drug discovery and development.
The company focuses on expanding its presence in the fast-growing Asia Pacific market. In June 2020, Charles River Laboratories (US) announced the opening of two new offices in China and Singapore to support sales and project management activities for biologics research.
The Jackson Laboratories (US)
The Jackson Laboratories has a portfolio of over 11,000 mice strains. The company caters to in-house innovative mice model development and distribution. For instance, in February 2020, the company launched the unique K18-hACE2 transgenic mouse model for coronavirus research. The company is utilizing state-of-the-art breeding techniques to grow a new K18-hACE2 transgenic mouse colony rapidly.
The company has received many grants, which support the development of its mice model business. Over the last few years, the company has received grants/funds from leading health organizations and academic institutes such as the National Cancer Institute (NCI), National Institutes of Health (NIH), The Mark Foundation for Cancer Research, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke, and Howard Hughes Medical Institute (HHMI) (US), among others. These grants have helped the company to develop new models, conduct specific studies on the models, compile genome-scale datasets for mice and humans, and examine various patterns of gene expression in mice to gain a better understanding of the genetic programs responsible for normal development and disease.
Inotiv, Inc. (US)
Envigo was acquired by Inotiv, Inc. (US) in November 2021. The company has built upon its core competency in preclinical and non-clinical contract research, research models and services, and animal care products. It offers a wide range of mice models and services and mice care products.
Inotiv has a strong focus on the developing Asia Pacific market. Envigo was the first international player to enter the Indian mice model and services market. This has helped the company to establish relationships with several leading life sciences researchers in India, including pharmaceutical, biotechnology, and biopharmaceutical companies, CROs, and private and government research institutes.
Mice Model Market by Model Types & Services (Inbred Mice, Genetically Engineered Mice), Technology (Microinjection, Nuclear Transfer, CRISPR/CAS9), Application (PDx Models, Drug Discovery), End User (Pharma, Biotech, CROs, CDMOs) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE